Latest News
Synairgen posts positive clinical trial data for SNG001
Shares of Synairgen caught a bid following the release of clinical trial results which appeared to show that its SNG001 formulation against Covid-19 might lower the risk of severe disease or death in the most at risk patients.
Tuesday preview: UK employment, Vodafone in focus
The market spotlight on Tuesday will be on UK employment with economists keen to see whether the labour market remains tight and how well - given the ongoing cost-of-living crisis - wage growth is holding up.
Europe close: Stocks end on mixed note amid recession concerns
European shares recovered from early selling but nevertheless finished on a mixed note following very weak industrial production and retail sales figures from China spooked investors worried about a global economic slowdown.
US close: Dow Jones narrowly extends gains
Wall Street stocks closed mostly lower on Monday ahead of some key retail data and earnings slated for later in the week.
London close: Stocks finish higher despite economic sentiment
London stocks managed a positive start to the week on Monday, reversing earlier losses despite ongoing concerns for the global economy after disappointing data from China and warnings the US could be headed for recession.
Sector movers: Defensives pace gains
Precious and industrial metals' miners paced gains at the start of the week despite the release of much weaker than expected activity data for the month of April out of the People's Republic of China reflecting the impact of Covid-19 restrictions.
Director dealings: Energean non-exec makes £1.35m sale, Gear4music CEO invests
Musical instruments and equipment retailer Gear4music was at the top of the list of director buys on Monday, after its chief executive officer spent over £90k on shares.
FTSE 100 movers: Phoenix Group boosted by upgrade; Aviva slumps
London’s FTSE 100 was up 0. 3% at 7,442. 61 in afternoon trade on Monday.
Broker tips: Kainos, Boohoo, Centrica
Analysts at Berenberg downgraded software outfit Kainos from 'buy' to 'hold' on Monday, stating the firm was now "stuck in an awkward spot".
US open: Major indices trade lower at the bell
Wall Street stocks opened lower on Monday ahead of some key retail data and earnings slated for later in the week.
FTSE 250 movers: Kainos hit by downgrade; Centrica cashes in
The FTSE 250 was down 0. 16% at 19,889. 05 at 1520 BST.
EU Commission slashes GDP growth forecasts, blames war, says worse possible
Brussels axed its short-term growth forecasts for both the European Union and the single currency area, not least as a result of the energy price shock triggered by the war in Ukraine.
Deutsche Bank and JP Morgan lower their target prices for Rolls Royce
Analysts at Deutsche Bank and JP Morgan lowered their target prices for Rolls Royce following medium-term guidance from the aerospace engineer.
Petropavlosk unable to pay coupon on $500m bond
Petropavlovsk shares tumbled on Monday after the gold miner said it was unable to pay the coupon due on 14 May of around $12. 36m in respect of a $500m bond issued in 2016.
New York Empire State manufacturing index unexpectedly falls
The New York Empire State manufacturing index surprisingly fell to -11. 6 in May, down from 24. 6 in April to miss market expectations for a reading of 17.
Carlyle to buy ManTech in $4.2bn deal
US buyout firm Carlyle has agreed to buy ManTech, a provider of technologies and solutions for national security programs, in a $4. 2bn deal.
Credit Suisse downgrades Boohoo
Credit Suisse has downgraded Boohoo on growing headwinds, sending the shares in the fast fashion retailer lower.
JetBlue Airways launches hostile takeover bid for Spirit Airlines.
US carrier JetBlue Airways has launched a hostile all-cash takeover bid for rival Spirit Airlines.
Europe midday: Stocks stay in the red as China slowdown worries hits sentiment
European shares trimmed early losses slightly at midday, but were still lower after very weak retail sales figures from China spooked investors worried about a global economic slowdown.
Lekoil applies to AQSE Growth Market, to delist from AIM
Lekoil announced on Monday that it has applied for admission of its shares to trading on the Access segment of the AQSE Growth Market of the Aquis Stock Exchange.